INT286067

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.37
First Reported 2008
Last Reported 2010
Negated 0
Speculated 1
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.21
Pain Relevance 0.05

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Igf1) extracellular region (Igf1)
Anatomy Link Frequency
podocytes 2
Igf1 (Mus musculus)
Pain Link Frequency Relevance Heat
Bioavailability 1 100.00 Very High Very High Very High
tolerance 17 25.20 Quite Low
alcohol 2 5.00 Very Low Very Low Very Low
Chronic pancreatitis 1 5.00 Very Low Very Low Very Low
anesthesia 1 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
agonist 1 5.00 Very Low Very Low Very Low
Kinase C 1 5.00 Very Low Very Low Very Low
isoflurane 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 19 97.96 Very High Very High Very High
Metabolic Syndrome 11 59.24 Quite High
Insulin Resistance 14 50.00 Quite Low
Disorder Of Lipid Metabolism 15 47.60 Quite Low
Hypoglycemia 1 40.00 Quite Low
Hyperinsulinism 3 36.16 Quite Low
Impaired Glucose Tolerance 17 25.20 Quite Low
Cancer 7 5.00 Very Low Very Low Very Low
Ocular Toxicity (including Many Sub-types) 5 5.00 Very Low Very Low Very Low
Diabetic Retinopathy 5 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
To determine whether IGF-1-mediated regulation of splicing was apparent at the protein level, podocytes were incubated with the pharmacological inhibitors of PKC (BIMI), and ELISA carried out on the protein extracted from the cells.
Spec (whether) Regulation (apparent) of Spec (whether) Regulation (regulation) of IGF-1-mediated in podocytes
1) Confidence 0.37 Published 2010 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2820781 Disease Relevance 0 Pain Relevance 0
In this regard, a polymorphism in the promoter region of the IGF-I gene was associated with low levels of IGF-I and increased risk of type-2 diabetes mellitus.[21] In addition to this, IGF-I binding proteins (IGFBPs) were not measured, which play an important role in regulating the bioavailability of IGF-I.
Regulation (role) of Regulation (regulating) of IGF-I associated with diabetes mellitus and bioavailability
2) Confidence 0.25 Published 2008 Journal International Journal of Diabetes in Developing Countries Section Body Doc Link PMC2772007 Disease Relevance 0.21 Pain Relevance 0.05

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox